News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Marvell's AI data‑center business is strong, but the stock's elevated multiples leave it vulnerable to a mid‑term correction.
  • NIQ's shares have rallied near their 52‑week high despite heavy leverage and restructuring, prompting short recommendations on execution risk.
  • Sinclair expects political ad revenue and a heavy sports calendar to lift 2026 EBITDA, but M&A questions linger.
  • Sterling held after stronger‑than‑expected UK GDP, while the dollar strengthened as markets priced higher odds of US rate hikes ahead of inflation data.
  • Traders are positioning for US inflation and Treasury moves, increasing near‑term volatility pressure across equities and FX markets.

Latest Articles

Maris-Tech Receives Repeat Order for Jupiter Family Products

Maris-Tech Receives Repeat Order for Jupiter Family Products

Maris-Tech Ltd., a Nasdaq-listed company specializing in edge computing and AI for defense applications, announced a repeat order from a distributor for its Jupiter family of miniature video encoder products. The order underscores continued adoption of Maris-Tech's technology in operational drone programs across Europe, reinforcing its position in …

Telos Corporation Announces Second Quarter 2026 Earnings

Telos Corporation Announces Second Quarter 2026 Earnings

Telos Corporation announced its second quarter 2026 financial results, making them available on its investor relations website. The company will host a live webcast to discuss these results, reflecting its ongoing commitment to transparency and investor engagement. Telos continues to provide advanced cybersecurity, identity management, and complian…

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Ernexa Therapeutics Strengthens Board with Veteran Biotech Executive David Polinsky as Company Approaches Clinical Stage

Ernexa Therapeutics (Nasdaq: ERNA) appointed veteran biotech executive David Polinsky to its board, strengthening leadership as the company prepares for IND submission of its lead cell therapy ERNA-101 in Q3 2026 and plans Phase 1 clinical trial initiation in Q4 2026. Polinsky brings over 25 years of experience in oncology, capital markets, and cor…

Nutanix Puts Agentic AI into Action for Enterprises

Nutanix Puts Agentic AI into Action for Enterprises

Nutanix announced the release of its Model Context Protocol (MCP) server for its Cloud Platform, an open-source solution designed to enable secure AI agent integration to automate hybrid cloud operations. This innovation allows enterprises to speed up cloud management tasks with AI assistants while maintaining strict security, granular access contr…

Hudbay Announces Board Appointment

Hudbay Announces Board Appointment

Hudbay Minerals Inc. announces the appointment of Thomas Schulz to its Board of Directors. Mr. Schulz brings extensive global leadership experience in the mining and industrial services sector, including executive roles at Bilfinger SE, FLSmidth, and Sandvik. His expertise is expected to support Hudbay's growth initiatives and strategic oversight a…

DeFi Development Corp. Releases June & July 2026 Recap Highlighting SOL Boost Framework, Organizational Streamlining, and Record Solana Network Growth

DeFi Development Corp. Releases June & July 2026 Recap Highlighting SOL Boost Framework, Organizational Streamlining, and Record Solana Network Growth

DeFi Development Corp. released its June and July 2026 business recap, highlighting significant progress in its SOL Boost Framework designed to enhance leveraged SOL exposure through strategic capital allocation and staking operations. The company streamlined its organization with executive transitions, expanded its validator presence in Japan, and…

Callan JMB Continues Longstanding Emergency Preparedness Support for the City of Chicago During Lollapalooza Weekend

Callan JMB Continues Longstanding Emergency Preparedness Support for the City of Chicago During Lollapalooza Weekend

Callan JMB Inc., a logistics company specializing in healthcare and emergency management support, successfully completed emergency preparedness operations for the 2026 Lollapalooza festival in Chicago. The engagement reinforces the company's longstanding partnership with Chicago's emergency services during major public events, demonstrating its exp…

BOS Secures $1.8 Million Purchase Order from New Customer

BOS Secures $1.8 Million Purchase Order from New Customer

BOS Better Online Solutions Ltd., listed on NASDAQ as BOSC, announced a $1.8 million purchase order from a new customer in the Israeli semiconductor sector. The order, spanning 2026-2027, reflects the company's diversification beyond its traditional defense segment and underscores its growing footprint in the semiconductor industry through its Supp…

Duolingo Appoints Sallie Krawcheck to Board of Directors

Duolingo Appoints Sallie Krawcheck to Board of Directors

Duolingo, the leading mobile language learning platform, announced the appointment of Sallie Krawcheck, a seasoned financial executive, to its Board of Directors. Krawcheck will join as an independent member and serve on the Audit, Risk and Compliance Committee, bringing over 30 years of experience in financial leadership and governance. This strat…

Tenable Co-CEO and CFO to Present at Upcoming Investor Events

Tenable Co-CEO and CFO to Present at Upcoming Investor Events

Tenable Holdings, a cybersecurity exposure management company, announced that CFO Matt Brown and Co-CEO Steve Vintz will present at the Stifel Tech Executive Summit and Piper Sandler Growth Frontiers Conference respectively. These presentations showcase leadership engagement with investors amidst their ongoing efforts to strengthen cybersecurity so…

NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout

NeOnc Reports Second Quarter 2026 Financial Results and Confirms August 12 Topline Phase 2a NEO100 Data Readout

NeOnc Technologies reported Q2 2026 financial results, highlighting increased R&D investment and a reduction in G&A expenses. The company completed topline analysis of its Phase 2a NEO100 study in recurrent IDH1-mutant high-grade glioma, with results scheduled for release on August 12, 2026. They secured UAE IND approvals for NEO100 and NEO212, exp…

Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma

Artelo Announces Enrollment of First Patient in a Phase 2 Clinical Trial Evaluating ART27.13 for Treatment of Glaucoma

Artelo Biosciences has begun dosing the first patient in the DREAM Phase 2 clinical study evaluating its orally administered synthetic cannabinoid, ART27.13, for lowering intraocular pressure in patients with glaucoma or ocular hypertension. The study is investigator-led, funded by Glaucoma UK and the HSC R&D Division, and aims to provide a novel g…

AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer

AIM ImmunoTech Reports Second Quarter 2026 Financial Results and Highlights Significant Operational Execution Advancing Ampligen® Toward Planned Phase 3 Development in Pancreatic Cancer

AIM ImmunoTech reported strong operational progress in their Ampligen pancreatic cancer program, completing enrollment and dosing in the Phase 2 DURIPANC trial. The company expects key clinical data in 2027 and is engaging partners for a planned pivotal Phase 3 study in metastatic pancreatic cancer. Financial position has improved significantly, su…

Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity

Kura Oncology Announces Publication in Blood Highlighting Ziftomenib’s Differentiated Binding Profile and Preclinical Activity

Kura Oncology announced the publication of a detailed preclinical study in the journal Blood, showcasing the discovery and differentiated binding profile of ziftomenib, its FDA-approved menin inhibitor for relapsed or refractory NPM1-mutated AML. The study highlights ziftomenib's potency, selectivity, and activity against resistance-associated MEN1…

Actelis Networks Powers Broadband to Remote Alaska Schools and Healthcare Facilities Through Regional Carrier Orders

Actelis Networks Powers Broadband to Remote Alaska Schools and Healthcare Facilities Through Regional Carrier Orders

Actelis Networks, a leader in cyber-hardened hybrid fiber-copper networking solutions, has secured multiple orders exceeding $100,000 from regional broadband carriers in Alaska. These carriers will deploy Actelis' technology to extend high-quality broadband connectivity to remote school districts and healthcare service facilities, helping bridge th…

Rush Street Interactive to Participate at the Oppenheimer 29th Annual Technology, Internet & Communications Conference

Rush Street Interactive to Participate at the Oppenheimer 29th Annual Technology, Internet & Communications Conference

Rush Street Interactive, a leading online casino and sports betting company operating in the US and Americas, announced its management will participate in a fireside chat at the upcoming Oppenheimer Annual Technology, Internet & Communications Conference. The company provides real-money mobile and online gaming services across multiple US states an…